Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1645 of 5804
-
Can a simple test spot pancreatic cancer before it starts?
Diagnosis Recruiting nowResearchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to save rectums in early cancer patients
Disease control OngoingThis is a single arm phase II study of neoadjuvant chemotherapy followed by local excision and post-operative chemoradiotherapy in patients with early stage, low rectal adenocarcinoma. After completion of pre-treatment tests/procedures (including pelvic MRI/ERUS; MRI is mandatory…
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New inhaled therapy for cystic fibrosis shows early promise
Disease control CompletedThis Phase 1/2, first-in-human study evaluated the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with cystic fibrosis (CF).
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a simple ultrasound replace CT scans for injured kids?
Diagnosis OngoingThe purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultraso…
Phase: PHASE4 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Cash for kids: can $333 a month boost a baby's brain?
Knowledge-focused OngoingRecent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's developm…
Phase: NA • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Blood test could revolutionize sarcoma monitoring
Knowledge-focused OngoingThis is a prospective multicenter biomarker study evaluating the prognostic impact of ctDNA detection at diagnosis in patients with Ewing sarcoma or osteosarcoma.
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New cocktail therapy hopes to tackle tough lung cancer
Disease control OngoingThe objective of this study is to investigate the safety, tolerability, and antitumor activity of novel combination therapies administered in participants with advanced EGFRm NSCLC.
Phase: PHASE1, PHASE2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a natural compound help prevent cancer in a rare disease?
Prevention CompletedFanconi anemia (FA) is an autosomal recessive disease characterized by progressive bone marrow failure, variable congenital abnormalities and a predisposition to malignancy, particularly acute myeloid leukemia (AML) and squamous cell carcinoma (SCC). Improved transplant outcomes …
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
New drug cocktail shows promise for aggressive breast cancer
Disease control OngoingThis is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.
Phase: PHASE1, PHASE2 • Sponsor: Kari Wisinski • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a simple Beta-Blocker stop a second cardiac arrest?
Disease control Recruiting nowA person who has experienced a cardiac arrest with no apparent cause is at risk of having recurrent cardiac arrest. Hence an implantable cardioverter-defibrillator (ICD) is recommended on empirical grounds. Today, there is no uniform way of approaching prevention of recurrence in…
Phase: PHASE4 • Sponsor: Bo Gregers Winkel • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New strategies help more teens get HPV vaccine
⭐️ VACCINE ⭐️ CompletedUCLA and Northeast Valley Health Center (NEVHC), a large, multi-site Federally Qualified Health Center (FQHC), are partnering to address underutilization of the prophylactic HPV vaccine among underserved, ethnic minority adolescents receiving care through FQHCs. We will use a clu…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
New eye scanner could sharpen diagnosis of corneal problems
Diagnosis Recruiting nowThis main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions. The primary goal will be achieved by using optical coherence to…
Sponsor: Oregon Health and Science University • Aim: Diagnosis
Last updated Jun 26, 2026 14:49 UTC
-
New combo tackles tough breast cancer brain metastases
Disease control CompletedThis research study is studying the combination of a drug called atezolizumab and a radiation procedure called stereotactic radiosurgery (SRS) as a possible treatment for triple-negative breast cancer that has spread to the brain. The interventions involved in this study are: *…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy combo shows promise against rare, tough ovarian cancer
Disease control OngoingPreclinical and early-phase clinical data suggest that immune modulation represents a treatment strategy that is worthy of further investigation in relapsed epithelial ovarian cancer. One method by which tumor cells may evade immune surveillance is by activation of the programmed…
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Quick MRI may outshine ultrasound for liver cancer detection
Diagnosis CompletedThis study compares gadolinium contrast-enhanced Abbreviated MRI (AMRI) to standard ultrasound for Hepatocellular Carcinoma (HCC) screening and surveillance in subjects with liver cirrhosis.
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New combo therapy shows promise for inoperable lung cancer
Disease control CompletedThis phase I trial studies the side effects and best dose of atezolizumab that can be given together with stereotactic body radiation therapy (SBRT) in treating patients with stage I non-small cell lung cancer that cannot be removed by surgery. Monoclonal antibodies, such as atez…
Phase: PHASE1 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New pill aims to tame tough blood pressure in kidney patients
Disease control CompletedThis is a Phase 2 randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy, safety, and pharmacokinetics of KBP-5074 in patients with moderate-to-severe chronic kidney disease and uncontrolled hypertension.
Phase: PHASE2 • Sponsor: KBP Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug combo shows promise against tough cancers
Disease control OngoingThe purpose of this study is to evaluate MEDI5752 and carboplatin and pemetrexed or paclitaxel or nab-paclitaxel in adult subjects with advanced solid tumors, when administered as a single agent or combined with chemotherapy.
Phase: PHASE1 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Nerve-Sparing radiation may help men keep sexual function after prostate cancer treatment
Symptom relief OngoingReduction of dose to or 'sparing' of neurovascular structures during stereotactic ablative body radiotherapy (SAbR) for localized prostate cancer will improve retention of sexual potency, while retaining excellent oncologic control and other secondary health-related quality of li…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Sleep your way to lower blood pressure? new study tests the idea
Disease control CompletedHypertension is the major risk factor for cardiovascular and cerebrovascular diseases worldwide. The escalating prevalence of inadequate sleep now parallels that of hypertension. Observational and experimental evidence favoring a causal relation between insufficient sleep and hyp…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC